0001237899-14-000019.txt : 20140213 0001237899-14-000019.hdr.sgml : 20140213 20140213183213 ACCESSION NUMBER: 0001237899-14-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140212 FILED AS OF DATE: 20140213 DATE AS OF CHANGE: 20140213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAHL NEIL CENTRAL INDEX KEY: 0001226689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 14608510 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2014-02-12 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226689 STAHL NEIL 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Research and Development S Common Stock 2014-02-12 4 M 0 40000.0 21.25 A 64391 D Common Stock 2014-02-12 4 F 0 2619.0 324.44 D 61772 D Common Stock 2014-02-12 4 F 0 20865.0 324.44 D 40907 D Common Stock 2014-02-12 4 M 0 8000.0 16.8 A 48907 D Common Stock 2014-02-12 4 F 0 414.0 324.44 D 48493 D Common Stock 2014-02-12 4 F 0 4234.0 324.44 D 44259 D Common Stock 2014-02-12 4 M 0 6548.0 16.8 A 50807 D Common Stock 2014-02-12 4 F 0 339.0 324.44 D 50468 D Common Stock 2014-02-12 4 F 0 3465.0 324.44 D 47003 D Common Stock 2014-02-13 4 S 0 1800.0 316.55 D 45203 D Common Stock 2014-02-13 4 S 0 5360.0 317.58 D 39843 D Common Stock 2014-02-13 4 S 0 6418.0 318.51 D 33425 D Common Stock 2014-02-13 4 S 0 3819.0 319.47 D 29606 D Common Stock 2014-02-13 4 S 0 3575.0 320.6 D 26031 D Common Stock 2014-02-13 4 S 0 1640.0 321.17 D 24391 D Common Stock 20000 I by GRAT Common Stock 5568 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 16.8 2014-02-12 4 M 0 8000.0 0.0 D 2018-12-17 Common Stock 8000 6548 D Non-Qualified Stock Option (right to buy) 16.8 2014-02-12 4 M 0 6548.0 0.0 D 2018-12-17 Common Stock 6548 0 D Non-Qualified Stock Option (right to buy) 21.25 2014-02-12 4 M 0 40000.0 0.0 D 2019-12-18 Common Stock 40000 80295 D Represents volume-weighted average price of sales of 1,800 shares of Company stock on February 13, 2014 at prices ranging from $316.07 to $316.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2014 at each separate price. Represents volume-weighted average price of sales of 5,360 shares of Company stock on February 13, 2014 at prices ranging from $317.00 to $317.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2014 at each separate price. Represents volume-weighted average price of sales of 6,418 shares of Company stock on February 13, 2014 at prices ranging from $318.00 to $318.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2014 at each separate price. Represents volume-weighted average price of sales of 3,819 shares of Company stock on February 13, 2014 at prices ranging from $319.00 to $319.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2014 at each separate price. Represents volume-weighted average price of sales of 3,575 shares of Company stock on February 13, 2014 at prices ranging from $320.10 to $320.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2014 at each separate price. Represents volume-weighted average price of sales of 1,640 shares of Company stock on February 13, 2014 at prices ranging from $321.00 to $321.38. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2014 at each separate price. The option became exercisable with respect to all shares underlying the option on December 31, 2011, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2011. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. The option became exercisable with respect to all shares underlying the option on December 31, 2012, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2012. /s/**Neil Stahl 2014-02-13